INCR News and Press, Intercure Ltd. From 04/04/22

InterCure (NASDAQ:INCR) reported Monday operating results for the fourth quarter with revenue of C$33M (NIS 80M), representing three times greater revenue Y/Y and 29% of sequential growth. Adjusted EBITDA is C$9M (NIS 21M), up 140% Y/Y; Adjusted EBITDA margin was 26%. Net ...

Fourth quarter 2021 Revenue and Adjusted EBITDA 2 of $33 million and $9 million, representing an increase of almost 200% and 140% YoY, respectively Record fiscal year 2021 revenue and Adjusted EBITDA 2 of $89 million and $23 million, representin...

Will release financial results for the fourth quarter of 2021 before market open on Monday, April 4, 2022 Webcast scheduled for same day at 8:30am ET NEW YORK, TORONTO, and HERZLIYA, Israel, April 03, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U...

NEW YORK, TORONTO, and HERZLIYA, Israel, March 30, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that it plans to release financial results for the fourth quarter of 2021 afte...

Nick Gastevich, one of our favorite commenters on Seeking Alpha, returns to the show to catch us up on the state of cannabis investing. Wave of new states legalizing cannabis now especially important in the face of long federal delays. Liking GTI but it's historically had slightly...

InterCure (NASDAQ:INCR) and Clever Leaves Holdings (NASDAQ:CLVR) announced the execution of an exclusive multi-year cultivation, marketing and distribution agreement. Per the terms, InterCure will have access to Clever Leaves’ high-THC medical cannabis flower to serve several medical c...

NEW YORK and TORONTO, and HERZLIYA, Israel, March 22, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) and Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”), a lea...

NEW YORK, TORONTO, and HERZLIYA, Israel, March 15, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in ROTH Capital&...

InterCure (NASDAQ:INCR) signed a definitive agreement with Altman Health LP to focus on the Israeli CBD product market. The newly formed company will focus on the new Israeli CBD product market following the Israeli Minister of Health's recent announcement that CBD would be removed from ...

The partnership will focus on the new CBD wellness market in Israel Israeli Minister of Health announced yesterday that CBD will be removed from the Dangerous Drugs Act Altman Health is the market leader in health and wellness with distribution across the country N...